CEBPA and acute myeloid leukemia: Inhibition of cell proliferation/viability potential, increased apoptosis in AML cell lines (MONOMAC6, NOMO-1, and U937) and xenotransplantation models.The impairment of AML stem cells (LSCs) self-renewal.↓ expression levels of MYC, CEBPA, and RARA.